BlackRock Institutional Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $74.1M | Buy |
1,054,386
+146,833
| +16% | +$10.3M | 0.01% | 1102 |
|
|
2016
Q3 | $64.4M | Buy |
907,553
+28,552
| +3% | +$2.03M | 0.01% | 1128 |
|
|
2016
Q2 | $43M | Sell |
879,001
-12,939
| -1% | -$633K | 0.01% | 1331 |
|
|
2016
Q1 | $56.5M | Buy |
891,940
+602
| +0.1% | +$38.1K | 0.01% | 1145 |
|
|
2015
Q4 | $100M | Buy |
891,338
+37,595
| +4% | +$4.22M | 0.02% | 841 |
|
|
2015
Q3 | $82.2M | Buy |
853,743
+128,534
| +18% | +$12.4M | 0.01% | 947 |
|
|
2015
Q2 | $74.3M | Buy |
725,209
+212,086
| +41% | +$21.7M | 0.01% | 1079 |
|
|
2015
Q1 | $31.9M | Buy |
513,123
+19,951
| +4% | +$1.24M | 0.01% | 1610 |
|
|
2014
Q4 | $21.6M | Buy |
493,172
+25,976
| +6% | +$1.14M | ﹤0.01% | 1848 |
|
|
2014
Q3 | $26.4M | Buy |
467,196
+387,071
| +483% | +$21.9M | ﹤0.01% | 1703 |
|
|
2014
Q2 | $3.6M | Sell |
80,125
-25,136
| -24% | -$1.13M | ﹤0.01% | 2923 |
|
|
2014
Q1 | $5.15M | Buy |
+105,261
| New | +$5.15M | ﹤0.01% | 2766 |
|